The VC landscape has split into two extremes. A few elite firms and sovereign wealth funds are funding mega-rounds for about 20-30 top AI companies, while the broader ecosystem of seed funds, Series A specialists, and new managers is getting crushed by a lack of capital and liquidity.

The current fundraising environment is the most binary in recent memory. Startups with the "right" narrative—AI-native, elite incubator pedigree, explosive growth—get funded easily. Companies with solid but non-hype metrics, like classic SaaS growers, are finding it nearly impossible to raise capital. The middle market has vanished.

According to investor sentiment, the window for startups to pivot to AI has closed. If a company doesn't have a disruptive AI offering in the market, venture capitalists have likely 'lost hope' and written them off, believing they lack the necessary speed to compete.

Despite headline figures suggesting a venture capital rebound, the funding landscape is highly concentrated. A handful of mega-deals in AI are taking the vast majority of capital, making it harder for the average B2B SaaS startup to raise funds and creating a deceptive market perception.

The focus on AI among institutional investors is so absolute that promising non-AI companies risk "dying of neglect" and being unable to secure follow-on funding. This creates a potential opportunity gap for angel investors to fund valuable businesses in overlooked sectors.

Aggregate venture capital investment figures are misleading. The market is becoming bimodal: a handful of elite AI companies absorb a disproportionate share of capital, while the vast majority of other startups, including 900+ unicorns, face a tougher fundraising and exit environment.

The AI boom is masking a broader trend: venture fundraising is at its lowest in 10 years. The 2021-22 period created an unsustainable number of new, small funds. Now, both LPs and founders are favoring established, long-term firms, causing capital to re-concentrate and the total number of funds to shrink.

The venture capital landscape is experiencing extreme concentration, with a handful of AI labs like OpenAI and Anthropic raising sums that rival half of the entire annual VC deployment. This capital sink into a few mega-private companies is a new phenomenon, unlike previous tech booms.

Despite a stable flow of absolute dollars into biotech venture, the sector's relative share of all VC funding has shrunk from ~14% to ~7%. This is due to the denominator effect of massive capital flooding into AI-focused tech companies.